Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells
Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells
复制标题
DOI:
10.1158/0008-5472.can-03-3480
复制
发表时间:
2004-03-15
期刊:
影响因子:
11.2
通讯作者:
Cramer, SD
中科院分区:
文献类型:
--
作者:
Rao, A;Coan, A;Cramer, SD
We investigated mechanisms by which genistein and 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] act synergistically to inhibit the growth of the human prostate cancer cell line LNCaP. We demonstrate that 1,25(OH)(2)D-3 and genistein cooperate to up-regulate the vitamin D receptor protein by increasing the stability of the vitamin D receptor. Genistein and 1,25(OH)(2)D-3 also cooperate to up-regulate the levels of p21/WAF1 (p21). Small interfering RNA-mediated knockdown of p21 expression showed that p21 is essential for significant growth inhibition of LNCaP cells in response to either compound or their combination. We conclude that one mechanism of synergism between genistein and 1,25(OH)(2)D-3 is through genistein modulation of vitamin D signaling.